Aura Biosciences (AURA) Capital Expenditures (2020 - 2026)

Aura Biosciences' Capital Expenditures history runs 7 years deep, the most recent figure standing at $46000.0 for Q1 2026.

• Quarterly Capital Expenditures changed N/A year-over-year to $46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $493000.0 (down 56.41% YoY) and the FY2025 annual result came in at $447000.0, down 64.33% from the prior year.
• Capital Expenditures was $46000.0 for Q1 2026 at Aura Biosciences, down from $176000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $1.7 million in Q4 2024 and bottomed at -$556000.0 in Q4 2022.
• A 5-year average of $126250.0 and a median of $112000.0 in 2022 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 1135.12% in 2024, while the deepest fall reached 269.08% in 2024.
• Aura Biosciences' Capital Expenditures stood at -$556000.0 in 2022, then soared by 69.78% to -$168000.0 in 2023, then surged by 1135.12% to $1.7 million in 2024, then tumbled by 89.88% to $176000.0 in 2025, then tumbled by 73.86% to $46000.0 in 2026.
• Business Quant data shows AURA's Capital Expenditures at $46000.0 in Q1 2026, $176000.0 in Q4 2025, and $45000.0 in Q3 2025.